| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $33.4M | +4.5% |
| Cost of Revenue | $23.7M | +11.1% |
| Gross Profit | $9.7M | -8.8% |
| R&D Expense | $1.4M | +53.3% |
| SG&A Expense | $3.7M | +35.3% |
| Operating Income | -$12.0M | -99.1% |
| Net Income | -$7.2M | -24.1% |
| EPS (Basic) | -$0.76 | +0.0% |
| EPS (Diluted) | -$0.76 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.5M | -29.8% |
| Short-term Investments | $4.5M | +201.2% |
| Accounts Receivable | $80K | +465.8% |
| Inventory | $4.9M | +21.9% |
| Current Assets | $26.6M | -10.8% |
| Total Assets | $39.8M | +4.2% |
| Current Liabilities | $4.2M | +11.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.9M | -67.3% |
| Capital Expenditures | $5.2M | +53.4% |
| Investing Cash Flow | -$6.6M | -3289.0% |
| Financing Cash Flow | $6.8M | -67.3% |
| Free Cash Flow | -$12.1M | -61.0% |
| +0.0% |
| Long-term Debt |
| $500K |
| +0.0% |
| Total Liabilities | $7.8M | +49.6% |
| Stockholders' Equity | $23.5M | -17.3% |